Table 1 Trk receptors, pc-Jun and pJNK expression in human astrocytomas of different grade of malignancy.
From: Neurotrophin receptors expression and JNK pathway activation in human astrocytomas
Case | Sex | Age | Histology/Grading | Prior treatment | pc-Jun | pJNK | panTrk | TrkA | TrkB | TrkC |
|---|---|---|---|---|---|---|---|---|---|---|
1 | F | 32 | Diffuse fibrillary astrocytoma/II | No | 0 | ND | 70 | ND | 0 | 0 |
2 | M | 56 | Diffuse fibrillary astrocytoma/II | No | 2 | 2 | 50 | ND | 30 | 60 |
3 | F | 38 | Diffuse fibrillary astrocytoma/II | No | 0 | 0 | 0 | 0 | 0 | 0 |
4 | M | 24 | Diffuse fibrillary astrocytoma/II | No | 10 | 10 | 10 | 10 | 5 | 5 |
5 | M | 11 | Diffuse fibrillary astrocytoma/II | No | 2 | 2 | 70 | 50 | ND | ND |
6 | F | 15 | Anaplastic astrocytoma/III | No | 0 | 0 | 2 | 1 | 5 | 0 |
7 | M | 62 | Anaplastic astrocytoma/III | No | 60 | 40 | ND | 50 | 60 | 40 |
8 | M | 56 | Anaplastic astrocytoma/III | No | 0 | 0 | 20 | 10 | 1 | ND |
9 | M | 46 | Anaplastic astrocytoma/III | No | 1 | 0 | 70 | 60 | 5 | 5 |
10 | M | 30 | Anaplastic astrocytoma/III | Yes | 2 | ND | 5 | ND | ND | ND |
11 | M | 35 | Anaplastic astrocytoma/III | No | 0 | 0 | 5 | 2 | 1 | 0 |
12 | F | 40 | Glioblastoma multiforme/IV | Yes | 0 | 0 | 0 | 0 | ND | ND |
13 | M | 19 | Glioblastoma multiforme/IV | No | 10 | 10 | 30 | 60 | 30 | 0 |
14 | M | 65 | Glioblastoma multiforme/IV | No | 90 | 90 | 20 | ND | 30 | ND |
15 | F | 57 | Glioblastoma multiforme/IV | No | 50 | 50 | 10 | ND | ND | ND |
16 | F | 53 | Glioblastoma multiforme/IV | Yes | 70 | 0 | 10 | ND | ND | 0 |
17 | M | 67 | Glioblastoma multiforme/IV | No | 70 | 0 | 1 | 1 | 0 | 0 |
18 | F | 60 | Glioblastoma multiforme/IV | Yes | 10 | 10 | 50 | ND | ND | 50 |
19 | M | 56 | Glioblastoma multiforme/IV | No | 70 | 90 | 80 | ND | 80 | 80 |
20 | F | 44 | Glioblastoma multiforme/IV | No | 0 | 90 | ND | 30 | 1 | 10 |
21 | M | 67 | Glioblastoma multiforme/IV | No | 80 | 80 | 10 | 20 | 10 | 5 |
22 | M | 60 | Glioblastoma multiforme/IV | No | 20 | 80 | 90 | ND | 60 | 75 |
23 | F | 59 | Glioblastoma multiforme/IV | No | 70 | 70 | 80 | ND | 20 | 20 |
24 | M | 25 | Glioblastoma multiforme/IV | Yes | 5 | 0 | 40 | ND | 10 | 10 |
25 | F | 66 | Glioblastoma multiforme/IV | No | 90 | 40 | 60 | 60 | 30 | 10 |
26 | M | 61 | Glioblastoma multiforme/IV | No | 25 | 10 | 90 | ND | 20 | 20 |
27 | F | 67 | Glioblastoma multiforme/IV | No | 60 | 10 | 90 | ND | 60 | 5 |
28 | M | 42 | Glioblastoma multiforme/IV | No | 0 | 0 | 70 | 70 | ND | ND |
29 | M | 47 | Glioblastoma multiforme/IV | Yes | 30 | 0 | 50 | 50 | ND | ND |
30 | F | 65 | Glioblastoma multiforme/IV | No | 50 | 70 | 90 | ND | 70 | 2 |
31 | M | 53 | Glioblastoma multiforme/IV | No | 70 | 60 | 30 | ND | ND | ND |
32 | F | 55 | Glioblastoma multiforme/IV | No | 60 | 40 | 30 | ND | 50 | 30 |
33 | M | 77 | Glioblastoma multiforme/IV | No | 1 | 0 | 30 | ND | 0 | 0 |